Viking Therapeutics Inc (VKTX) — the peer cohort
As of 2026-11-10 — scores re-bake nightly. Cohort = shared Closelooknet index membership first, then sector. Diary readings, not advice.
Viking Therapeutics Inc ranks 16 of 16 in its cohort on the Closelooknet composite (28/100) — the cohort is led by Halozyme Therapeutics Inc at 70/100.
| Name | Composite | Momentum | Quality | Valuation | Signal | Off 52w high |
|---|---|---|---|---|---|---|
| VKTX Viking Therapeutics Inc | 28 | 29 | 2 | — | bull | 32.8% |
| RACE Ferrari NV | 66 | 79 | 83 | 23 | watch | 15.5% |
| LLY Eli Lilly and Company | 64 | 91 | 90 | 22 | bull | 2.8% |
| REGN Regeneron Pharmaceuticals Inc | 64 | 84 | 72 | 45 | bull | 7.2% |
| DXCM DexCom Inc | 62 | 67 | 79 | 34 | watch | 12.4% |
| HDB HDFC Bank Limited ADR | 62 | 52 | 66 | 80 | bull | 28.9% |
| TOST Toast Inc | 62 | 76 | 51 | 41 | watch | 12.5% |
| GMED Globus Medical | 60 | 37 | 65 | 53 | bull | 24.7% |
| ONON On Holding Ltd | 60 | 45 | 69 | 45 | watch | 26.5% |
| VRSK Verisk Analytics Inc | 60 | 69 | 88 | 33 | neutral | 19.2% |
| FAST Fastenal Company | 59 | 83 | 71 | 19 | bull | 0.8% |
| IDXX IDEXX Laboratories Inc | 59 | 71 | 85 | 17 | bull | 8.2% |
| ZEAL.CO Zealand Pharma A/S | 59 | 11 | 71 | 77 | bull | 55.9% |
| HALO Halozyme Therapeutics Inc | 70 | 76 | 94 | 36 | info | 23.1% |
| ARGX.BR Argen-X | 65 | 85 | 75 | 28 | ok | 6.6% |
| ONC BeOne Medicines AG | 65 | 91 | 64 | 29 | ok | 0.2% |
Scores are relative readings across the Closelooknet coverage universe — methodology in the company-scoring explainer. Signal lights come from the nightly signal board.
FAQ · from the current data · as of 2026-11-10
Quick answers
Who are Viking Therapeutics Inc's peers in the Closelooknet universe?
The cohort is drawn from shared Closelooknet index membership first, then sector: Ferrari NV (RACE), Eli Lilly and Company (LLY), Regeneron Pharmaceuticals Inc (REGN), DexCom Inc (DXCM), HDFC Bank Limited ADR (HDB), Toast Inc (TOST), Globus Medical (GMED), On Holding Ltd (ONON) and others, as of 2026-11-10.
How does VKTX score against its peers?
Viking Therapeutics Inc's composite reads 28/100, ranking 16 of 16 in its cohort as of 2026-11-10; the cohort's highest composite is Halozyme Therapeutics Inc at 70/100. Closelooknet scores are research diary readings, not ratings or advice.
Related in the Closelooknet universe
same Closelooknet index seat first, then Biotechnology. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.
- RACE Ferrari NV
- LLY Eli Lilly and Company
- REGN Regeneron Pharmaceuticals Inc
- DXCM DexCom Inc
- HDB HDFC Bank Limited ADR
- TOST Toast Inc
- GMED Globus Medical
- ONON On Holding Ltd
- VRSK Verisk Analytics Inc
- FAST Fastenal Company
- IDXX IDEXX Laboratories Inc
- ZEAL.CO Zealand Pharma A/S
- HALO Halozyme Therapeutics Incindustry
- ARGX.BR Argen-Xindustry
- ONC BeOne Medicines AGindustry
- UCB.BR UCB SAindustry
- ARGX argenx NV ADRindustry
- RIGL Rigel Pharmaceuticals Incindustry
- REPL Replimune Group Incindustry
- KOD Kodiak Sciences Incindustry